Signal Genetics Inks $13.3M Deal to Commercialize DiagnoCure's Colorectal Cancer Test, Buy CLIA Lab

Under the terms of the transaction, DiagnoCure will also advance the development of certain genomic tests for Signal Genetics.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.